Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis
NCT03573505 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis
- Lead sponsor
- Biogen
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 24, 2018
- Completion date
- November 14, 2019
- Enrollment
- 109 (actual)
- Sites
- 90
Conditions
As the registry lists them; a condition with its own page is linked.